Biotechnology Jobs

• Stevenage
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's Chemical Manufacturing & Control function, identifying and sizing AI opportunities across process development science for oligonucleotides, ADCs and monoclonal antibodies. Partners with forward deployed engineering pods to turn ambiguous business problems into scoped, buildable products, and shapes self-driving lab and in silico modelling initiatives.

Self-Driving Labs · Agentic Workflows · Physical AI

• London
• Hybrid · 2–3 days in office
• Senior

Sits within GSK's CMC function, identifying and sizing AI opportunities across process development science for oligonucleotides, ADCs and monoclonal antibodies. Partners with forward deployed engineering pods to turn ambiguous business problems into scoped, buildable products, and shapes self-driving lab and in silico modelling initiatives.

AI Platforms · ML Platforms

• Opfikon, Switzerland
• Hybrid · 3 days in office
• US$212,000 – US$251,000 pa
• Director

Leads the full statistical contribution to a clinical development programme, defining statistical strategy for trial design, analysis and regulatory submissions, and representing Biostatistics in interactions with the FDA, EMA and PMDA. Also manages outsourcing to CROs and internal statistical programmers, and supports departmental improvement initiatives.

SAS · R

• Cambridge
• Hybrid
• Senior

Hands-on bioanalytical role developing, optimising and running LC-MS/MS assays for small and large molecule DMPK studies in an early discovery setting, analysing matrices such as plasma, blood, brain, bile, faeces and urine. Combines complex mass spectrometry troubleshooting and method development with leading scientific projects, mentoring colleagues and driving novel assay innovation in a matrix team.

UPLC-MS · LC-MS/MS · Mass Spectrometry

• Abingdon
• Lead
• Permanent

Acts as the single front door between Evotec's Drug Discovery Platforms and the global In Silico & AI organisation, owning demand, relationships and the in silico roadmap. Translates platform science needs across DMPK, ADME/Tox, predictive safety, screening and omics into prioritised AI requirements, then orchestrates delivery across capability units. Carries a commercial mandate, contributing to client proposals, pricing and evidencing value such as margin uplift and cycle time.

• London
• Hybrid
• Director · manages people

Leads global operational delivery of early development oncology programs, managing Clinical Project Managers, Monitoring Leads and CTAs. Owns the clinical development plan, CRO and site selection strategy, budgets and timelines, and serves on Asset Teams. Requires deep first-in-human and Phase I oncology trial expertise.

Microsoft Office

• Burgess Hill
• Hybrid
• £49 – £86 ph
• Lead
• Contract

Leads authoring, review and lifecycle management of clinical and performance evaluation documentation for a global diagnostics organisation, including protocols, study reports, investigator brochures and regulatory submissions. Works cross-functionally with regulatory, quality, R&D and medical affairs teams, conducting literature reviews and synthesising complex clinical data under IVDR and GCP.

AI-enabled tools

• Remote Opportunity - United Kingdom
• Remote
• £136,500 – £167,200 pa
• Director

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead for regulatory interactions and study design from Phase 1-3. Perform and oversee modeling and simulation with tools such as WinNonlin, Monolix, NONMEM and R, and author regulatory sections for IBs, INDs and NDAs. Part of a Pharmacometrics team spanning clinical pharmacology, pharmacometrics and translational modeling, working end-to-end across discovery and development.

WinNonlin · Monolix · NONMEM +1

• Remote Opportunity - United States
• Remote
• US$261,800 – US$346,060 pa
• Director

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead and regulatory representative. Oversee modeling and simulation (population PK, PK-PD, exposure-response) and provide pharmacology input on Phase 1-3 study designs. Work cross-functionally with clinical, translational and discovery teams in an end-to-end drug development environment.

WinNonlin · Monolix · NONMEM +1

• London
• Hybrid
• Director

Leads end-to-end translational strategy for neurodegenerative and neuromuscular programs, bridging preclinical research to Phase 1–2 clinical development. Accountable for biomarker strategy, clinical endpoint selection and early-phase trial design, and serves as the Translational Medicine representative within global cross-functional project and clinical trial teams.

• London
• Hybrid
• Director

Leads medical evaluation of external innovation and business development opportunities across Ipsen's oncology portfolio, assessing unmet need, clinical value and target product profiles. Sits on the Global Oncology Medical Leadership team, shaping cross-asset strategy and preparing new products for integration, while engaging external experts and scientific societies.

ESMO · ASCO · AACR

• London
• Hybrid
• Senior
• Permanent

Enterprise sales role focused on landing new logos across pharmaceutical and biotech companies, owning the full cycle from prospecting to close. Involves navigating complex multi-stakeholder deals with scientific, technical, procurement and executive buyers, and translating an AI-native biology platform into customer value. Partners closely with founders, product and science teams to refine go-to-market playbooks.

• London
• Hybrid
• Junior
• Permanent

Hands-on business development role researching pharma and biotech accounts, writing outreach, and owning CRM pipeline hygiene in HubSpot. Works directly with founders and the head of sales, building sales materials and AI workflows while coordinating with the science team ahead of customer meetings.

HubSpot · LinkedIn

• Reading
• Lead

Provides principal-level statistical leadership across Phase II and III clinical trials, independently leading SAP authoring and review while supporting integration activities across studies and programmes. Acts as a proactive statistical partner to clinical, programming and regulatory teams, ensuring compliant, high-quality outputs are delivered on time. Requires strong R programming and immunology therapeutic area exposure is desirable.

R

• Maidenhead
• Hybrid · 3 days in office
• Director

Leads strategic sourcing and evaluation of external innovation opportunities in Haematology, identifying preclinical to Phase 1 assets and shaping early partnering strategies. Sits on the Therapeutic Area Leadership Team, co-leads New Product Opportunity reviews, drives cross-functional due diligence and works with Business Development on deal execution. Hybrid, three days a week at an R&D hub site.